Santen Pharmaceutical Co.... (SNPHY)
PNK: SNPHY
· Real-Time Price · USD
10.42
0.13 (1.31%)
At close: May 01, 2025, 3:29 PM
1.31% (1D)
| Bid | 9.38 |
| Market Cap | 3.67B |
| Revenue (ttm) | 304.35B |
| Net Income (ttm) | 26.86B |
| EPS (ttm) | 0.55 |
| PE Ratio (ttm) | 18.95 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 10.42 |
| Volume | 1,984 |
| Avg. Volume (20D) | 6,773 |
| Open | 9.65 |
| Previous Close | 10.29 |
| Day's Range | 9.65 - 10.42 |
| 52-Week Range | 8.65 - 13.00 |
| Beta | 0.20 |
About SNPHY
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 31, 2011
Employees 3,744
Stock Exchange PNK
Ticker Symbol SNPHY
Website https://www.santen.com